WASHINGTON — The Centers for Medicare & Medicaid Services (CMS) is proposing a nearly 3.4% cutopens in a new tab or window to the “conversion factor” used to set the Medicare Physician Fee Schedule for 2024, and physician groups are none too happy about it. “The proposed 2024 Medicare Physician Fee Schedule (PFS) raises significant concerns for […]
July 14, 2023 – “I’ve always been a little wary of needles,” Heather, 65, a resident of Southern California, said as she reminisced about a long-ago high school biology class. The instructor asked them all to prick their finger to find out their blood type. It took her the whole hour to work up her […]
In this exclusive video, Harlan Krumholz, MD, SM, of the Yale School of Medicine and Yale New Haven Hospital in Connecticut, discusses uses of large language models like ChatGPT in healthcare settings and how to use new artificial intelligence (AI) technology responsibly. Krumholz is the director of the Center for Outcomes Research and Evaluation, the Harold H. […]
Twice-weekly subcutaneous ketamine helped alleviate symptoms of treatment-resistant depression, according to the phase III KADS study. Among those who received at least one flexible treatment dose (0.5-0.9 mg/kg), ketamine was more than 12-times better at inducing remission of depression than the benzodiazepine midazolam (remission rate 19.6% vs 2.0%, OR 12.1, 95% CI 2.1-69.2, P=0.005), reported Colleen […]
When timely angioplasty is unavailable to older ST-segment elevation myocardial infarction (STEMI) patients, a modified pharmaco-invasive reperfusion strategy could be reasonable, according to the STREAM-2 trial. Half-dose tenecteplase (TNKase) produced ECG changes that were at least comparable to those after primary percutaneous coronary intervention (PCI) in a cohort presenting within 3 hours of STEMI symptom […]
Acute kidney injury (AKI) didn’t predict worsening kidney function in people with chronic kidney disease (CKD), a prospective study showed. According to findings from the Chronic Renal Insufficiency Cohort (CRIC) study, CKD patients hospitalized for AKI saw a statistically insignificant drop in estimated glomerular filtration rate (eGFR) during a nearly 4-year follow-up period, reported Chi-yuan […]
It’s widely known that length of stay is one of the most important determinants of success in substance use disorder (SUD) treatment. Data has proven that the longer we can keep patients engaged, the betteropens in a new tab or window their long-term prognosis. Unfortunately, it’s also one of the hardest factors for providers to overcome. Between […]
The range of COVID-19 symptoms varies-; some feel a mild cold, others are hospitalized, while others perish. Many studies have linked the severity of COVID-19 symptoms with an individual’s biological factors, but less is known about the impact of non-biological factors, such as the environment in which people live. A new study that published on […]
FDA approved expanded use of inclisiran (Leqvio) for primary hyperlipidemiaopens in a new tab or window atop its existing indications of atherosclerotic cardiovascular and heterozygous familial hypercholesterolemia, Novartis announced. An estimate gives users of low-dose colchicineopens in a new tab or window an extra 2 years free of myocardial infarction, stroke, or cardiovascular death in a lifetime. (European Journal […]